<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#Cover" roleURI="http://gcanrx.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#BalanceSheets" roleURI="http://gcanrx.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#BalanceSheetsParenthetical" roleURI="http://gcanrx.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#StatementsOfOperations" roleURI="http://gcanrx.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#StatementsOfStockholdersDeficiency" roleURI="http://gcanrx.com/role/StatementsOfStockholdersDeficiency" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#StatementsOfStockholdersDeficiencyParenthetical" roleURI="http://gcanrx.com/role/StatementsOfStockholdersDeficiencyParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#StatementsOfCashFlows" roleURI="http://gcanrx.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingPolicies" roleURI="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#GoingConcern" roleURI="http://gcanrx.com/role/GoingConcern" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#RightOfFirstRefusalAgreement" roleURI="http://gcanrx.com/role/RightOfFirstRefusalAgreement" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#LoansPayableToRelatedParties" roleURI="http://gcanrx.com/role/LoansPayableToRelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NotesPayableToThirdParties" roleURI="http://gcanrx.com/role/NotesPayableToThirdParties" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#DerivativeLiability" roleURI="http://gcanrx.com/role/DerivativeLiability" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#CapitalStockAndWarrants" roleURI="http://gcanrx.com/role/CapitalStockAndWarrants" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#IncomeTaxes" roleURI="http://gcanrx.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#CommitmentsAndContingencies" roleURI="http://gcanrx.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#RestatementOfPreviouslyIssuedFinancialStatements" roleURI="http://gcanrx.com/role/RestatementOfPreviouslyIssuedFinancialStatements" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#SubsequentEvents" roleURI="http://gcanrx.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#LoansPayableToRelatedPartiesTables" roleURI="http://gcanrx.com/role/LoansPayableToRelatedPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NotesPayableToThirdPartiesTables" roleURI="http://gcanrx.com/role/NotesPayableToThirdPartiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#DerivativeLiabilityTables" roleURI="http://gcanrx.com/role/DerivativeLiabilityTables" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#GoingConcernDetailsNarrative" roleURI="http://gcanrx.com/role/GoingConcernDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#RightOfFirstRefusalAgreementDetailsNarrative" roleURI="http://gcanrx.com/role/RightOfFirstRefusalAgreementDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfLoansPayableToRelatedPartiesDetails" roleURI="http://gcanrx.com/role/ScheduleOfLoansPayableToRelatedPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfLoansPayableToRelatedPartiesDetailsParenthetical" roleURI="http://gcanrx.com/role/ScheduleOfLoansPayableToRelatedPartiesDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#LoansPayableToRelatedPartiesDetailsNarrative" roleURI="http://gcanrx.com/role/LoansPayableToRelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfNotesPayableToThirdPartiesDetails" roleURI="http://gcanrx.com/role/ScheduleOfNotesPayableToThirdPartiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfNotesPayableToThirdPartiesDetailsParenthetical" roleURI="http://gcanrx.com/role/ScheduleOfNotesPayableToThirdPartiesDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfPrepayAmountAndDateDescriptionDetails" roleURI="http://gcanrx.com/role/ScheduleOfPrepayAmountAndDateDescriptionDetails" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#NotesPayableToThirdPartiesDetailsNarrative" roleURI="http://gcanrx.com/role/NotesPayableToThirdPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfDerivativeLiabilityDetails" roleURI="http://gcanrx.com/role/ScheduleOfDerivativeLiabilityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#ScheduleOfDerivativeLiabilityDetailsParenthetical" roleURI="http://gcanrx.com/role/ScheduleOfDerivativeLiabilityDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#DerivativeLiabilityDetailsNarrative" roleURI="http://gcanrx.com/role/DerivativeLiabilityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#CapitalStockAndWarrantsDetailsNarrative" roleURI="http://gcanrx.com/role/CapitalStockAndWarrantsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://gcanrx.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="gcan-20260630.xsd#RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" roleURI="http://gcanrx.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetIncludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedEmployeeBenefitsCurrent" xlink:label="loc_us-gaapAccruedEmployeeBenefitsCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccruedEmployeeBenefitsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherCostAndExpenseOperating" xlink:label="loc_us-gaapOtherCostAndExpenseOperating" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherCostAndExpenseOperating" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_GainOnCancellationOfDebt" xlink:label="loc_GCANGainOnCancellationOfDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_GCANGainOnCancellationOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_GainOnCancellationOfPreferredStock" xlink:label="loc_GCANGainOnCancellationOfPreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_GCANGainOnCancellationOfPreferredStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_NoteDefaultPenaltiesAndInterest" xlink:label="loc_GCANNoteDefaultPenaltiesAndInterest" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_GCANNoteDefaultPenaltiesAndInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/StatementsOfStockholdersDeficiency" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Deficiency (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/StatementsOfStockholdersDeficiencyParenthetical" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Deficiency (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/StatementsOfCashFlows" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_IssuanceOfCommonStockForAccruedCompensation" xlink:label="loc_GCANIssuanceOfCommonStockForAccruedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCANIssuanceOfCommonStockForAccruedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_NoteDefaultPenaltiesAndInterest" xlink:label="loc_GCANNoteDefaultPenaltiesAndInterest" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCANNoteDefaultPenaltiesAndInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_GainOnCancellationOfDebt" xlink:label="loc_GCANGainOnCancellationOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCANGainOnCancellationOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gcan-20260630.xsd#GCAN_GainOnCancellationOfPreferredStock" xlink:label="loc_GCANGainOnCancellationOfPreferredStock" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GCANGainOnCancellationOfPreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/GoingConcern" xlink:title="999009 - Disclosure - GOING CONCERN" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/RightOfFirstRefusalAgreement" xlink:title="999010 - Disclosure - RIGHT OF FIRST REFUSAL AGREEMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/LoansPayableToRelatedParties" xlink:title="999011 - Disclosure - LOANS PAYABLE TO RELATED PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NotesPayableToThirdParties" xlink:title="999012 - Disclosure - NOTES PAYABLE TO THIRD PARTIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/DerivativeLiability" xlink:title="999013 - Disclosure - DERIVATIVE LIABILITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/CapitalStockAndWarrants" xlink:title="999014 - Disclosure - CAPITAL STOCK AND WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/IncomeTaxes" xlink:title="999015 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/CommitmentsAndContingencies" xlink:title="999016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/RestatementOfPreviouslyIssuedFinancialStatements" xlink:title="999017 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/SubsequentEvents" xlink:title="999018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999019 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/LoansPayableToRelatedPartiesTables" xlink:title="999020 - Disclosure - LOANS PAYABLE TO RELATED PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NotesPayableToThirdPartiesTables" xlink:title="999021 - Disclosure - NOTES PAYABLE TO THIRD PARTIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/DerivativeLiabilityTables" xlink:title="999022 - Disclosure - DERIVATIVE LIABILITY (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NatureOfOperationsAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999023 - Disclosure - NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/GoingConcernDetailsNarrative" xlink:title="999024 - Disclosure - GOING CONCERN (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/RightOfFirstRefusalAgreementDetailsNarrative" xlink:title="999025 - Disclosure - RIGHT OF FIRST REFUSAL AGREEMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfLoansPayableToRelatedPartiesDetails" xlink:title="999026 - Disclosure - SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfLoansPayableToRelatedPartiesDetailsParenthetical" xlink:title="999027 - Disclosure - SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/LoansPayableToRelatedPartiesDetailsNarrative" xlink:title="999028 - Disclosure - LOANS PAYABLE TO RELATED PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfNotesPayableToThirdPartiesDetails" xlink:title="999029 - Disclosure - SCHEDULE OF NOTES PAYABLE TO THIRD PARTIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfNotesPayableToThirdPartiesDetailsParenthetical" xlink:title="999030 - Disclosure - SCHEDULE OF NOTES PAYABLE TO THIRD PARTIES (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfPrepayAmountAndDateDescriptionDetails" xlink:title="999031 - Disclosure - SCHEDULE OF PREPAY AMOUNT AND DATE DESCRIPTION (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/NotesPayableToThirdPartiesDetailsNarrative" xlink:title="999032 - Disclosure - NOTES PAYABLE TO THIRD PARTIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfDerivativeLiabilityDetails" xlink:title="999033 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/ScheduleOfDerivativeLiabilityDetailsParenthetical" xlink:title="999034 - Disclosure - SCHEDULE OF DERIVATIVE LIABILITY (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/DerivativeLiabilityDetailsNarrative" xlink:title="999035 - Disclosure - DERIVATIVE LIABILITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/CapitalStockAndWarrantsDetailsNarrative" xlink:title="999036 - Disclosure - CAPITAL STOCK AND WARRANTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999037 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://gcanrx.com/role/RestatementOfPreviouslyIssuedFinancialStatementsDetailsNarrative" xlink:title="999038 - Disclosure - RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details Narrative)" />
</link:linkbase>
